Recombivax-HB (Recombivax-HB)

All References

• Cassidy WM, Watson B, Ioli VA, Williams K, Bird S, West DJ. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics. 2001;107:626-31.
  [PubMed Abstract]
• Centers for Disease Control and Prevention (CDC). New pediatric formulation of Recombivax HB. MMWR Morb Mortal Wkly Rep. 1993;42:686-7.
  [PubMed Abstract]
• Coates T, Wilson R, Patrick G, André F, Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther. 2001;23:392-403.
  [PubMed Abstract]
• Duval B, Boulianne N, De Serres G, et al. Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children. Vaccine. 2000;18:1467-72.
  [PubMed Abstract]
• Goolsby PL. Erythema nodosum after Recombivax HB hepatitis B vaccine. N Engl J Med. 1989;321:1198-9.
  [PubMed Abstract]
• Jilg W, Schmidt M, Deinhardt F. Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis. 1989;160:766-9.
  [PubMed Abstract]
• Lacson E, Teng M, Ong J, Vienneau L, Ofsthun N, Lazarus JM. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int. 2005;9:367-75.
  [PubMed Abstract]
• Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med. 1997;336:196-204.
  [PubMed Abstract]
• Pinto M, Dawar M, Krajden M, Naus M, Scheifele DW. Will Infant Hepatitis B Vaccination Protect Into Adulthood?: Extended Canadian Experience After a 2-, 4- and 6-month Immunization Schedule. Pediatr Infect Dis J. 2017;36:609-615.
  [PubMed Abstract]
• Rustgi VK, Schleupner CJ, Krause DS. Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults. Vaccine. 1995;13:1665-8.
  [PubMed Abstract]
• Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA. 1987;257:2612-6.
  [PubMed Abstract]
• Treadwell TL, Keeffe EB, Lake J, et al. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med. 1993;95:584-8.
  [PubMed Abstract]
• Venters C, Graham W, Cassidy W. Recombivax-HB: perspectives past, present and future. Expert Rev Vaccines. 2004;3:119-29.
  [PubMed Abstract]